FDA approves BridgeBio Pharma's new heart drug
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
She succeeds Stuart Aitken, who will step down from his role as senior vice president and chief merchandising and marketing officer at the end of the year.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
Meijer honored exceptional team members with its 2024 Legacy Awards, recognizing individuals who embody the company’s core values of leadership, innovation, and service. Regional Vice President Maureen Mitchell received the prestigious Fred Meijer Award.
A recent NACDS poll highlights strong voter support for PBM reform and the significant influence healthcare issues had on voters' decisions in the 2024 elections.
This is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
The announcement was made by CEO Kevin Murphy, who highlighted Stalbaum’s extensive experience and contributions to the company since joining in 2019.
Bruce Kneeland, Principal Consultant of Kneeland Services and industry expert, has joined Finch Marketing and GRX Marketing to drive its growth initiatives.
During Thanksgiving week, when a customer includes Meijer brand food in their purchase, Meijer's Simply Give program will benefit a neighbor in need.
As part of National Diabetes Awareness Month, Cardinal Health is focusing on the Hispanic American population, which is one of the top high-risk populations for diabetes.
Target's third-quarter results showed modest 0.3% sales growth, driven by higher traffic and strong digital performance. However, profitability fell short due to rising costs and cautious consumer spending. The retailer lowered its full-year earnings forecast, and its stock plunged over 20%.
Dollar sales in the F&B sector rose by 2.6% this year, driven by a 1.6% increase in price/mix and a 1.1% boost in volume sales.
The model, based on Greater Than One's proprietary technology, leverages nearly 25 years of data and health industry marketing experience, enabling the agency to predict and achieve measurable improvements in a client's marketing performance.